Oncovin (Intravenous)
Generic name:vincristine (intravenous route) [ vin-KRIS-teen ]
Drug class:Mitotic inhibitors
Medically reviewed by Drugs.com. Last updated on Apr 10, 2022.
For intravenous use only; fatal if given by other routes. To reduce the potential for fatal medication errors due to incorrect route of administration proper dilution, product labeling and packaging is necessary. Intravenous needle or catheter must be properly positioned before any vinCRIStine is injected, as leakage into the surrounding tissue may cause considerable irritation. If extravasation occurs, the injection should be discontinued immediately, and any remaining portion of the dose should then be introduced into another vein. Local injection of hyaluronidase and the application of moderate heat to the area of leakage help disperse the drug and are thought to minimize discomfort and the possibility of cellulitis.
The Oncovin brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Commonly used brand name(s)
In the U.S.
- Oncovin
- Vincasar PFS
Available Dosage Forms:
- Solution
Therapeutic Class: Antineoplastic Agent
Pharmacologic Class: Mitotic Inhibitor
Uses for Oncovin
Vincristine belongs to the group of medicines known as antineoplastic agents. It is used to treat some kinds of cancer as well as some noncancerous conditions.
Vincristine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by vincristine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, such as hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.
Before you begin treatment with vincristine, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Vincristine is to be administered only by or under the immediate supervision of your doctor.
Before using Oncovin
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
This medicine has been tested in children and has not been shown to cause different side effects or problems than it does in adults.
Geriatric
Nervous system effects may be more likely to occur in the elderly, who are usually more sensitive to the effects of vincristine.
Breastfeeding
There are no adequate studies..
